Home › Funds › Principal Global Investors › DNLI
Principal Global Investors position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.42M sh
Reported value held$36.52M
Portfolio Weight0.02%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 303.83K | $15.33M | New |
| Q4 2021 | 330.27K | $14.73M | Add |
| Q1 2022 | 269.00K | $8.65M | Reduce |
| Q2 2022 | 267.73K | $7.88M | Hold |
| Q3 2022 | 545.87K | $16.75M | Add |
| Q4 2022 | 526.46K | $14.64M | Reduce |
| Q1 2023 | 488.96K | $11.27M | Reduce |
| Q2 2023 | 686.49K | $20.26M | Add |
| Q3 2023 | 680.08K | $14.03M | Reduce |
| Q4 2023 | 1.07M | $23.04M | Add |
| Q1 2024 | 1.12M | $23.03M | Add |
| Q2 2024 | 1.09M | $25.28M | Reduce |
| Q3 2024 | 1.24M | $36.08M | Add |
| Q4 2024 | 1.13M | $23.05M | Reduce |
| Q1 2025 | 1.08M | $14.70M | Reduce |
| Q2 2025 | 1.07M | $15.01M | Reduce |
| Q3 2025 | 1.27M | $18.46M | Add |
| Q4 2025 | 1.52M | $25.16M | Add |
| Q1 2026 | 1.48M | $28.39M | Reduce |
| Q2 2026 | 1.42M | $36.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Norges Bank Investment Management 2.82M sh · $72.65M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026